Point-of-Care Biosensors for Medical Diagnosis

A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensors and Healthcare".

Deadline for manuscript submissions: closed (15 November 2021) | Viewed by 8148

Special Issue Editors


E-Mail Website
Guest Editor
Department of Mechanical Engineering, University of British Columbia, BC V6J 1Z4, Canada
Interests: point-of-care technologies; lab-on-a-chip; analytical chemistry; nanotechnology; stem cells; tissue engineering; bioengineering; cell and molecular biology; biochemistry
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2R3, 7 Canada
Interests: biosensing; stem cells; tissue engineering; microfluidics; biomaterials

Special Issue Information

Dear Colleague,

Infectious diseases such as dengue, human immunodeficiency virus (HIV) and malaria have become the leading causes of death in the world. Recently, the COVID-19 outbreak has become a global pandemic. The deleterious effects of these viruses have prompted the development of point-of-care (POC) biosensors for rapid testing to curtail the spread of diseases. With advances in microfluidic technologies, it is possible to detect disease-specific biomarkers (e.g., proteins, nucleic acids, etc.) with typically robust, low-cost and portable biosensors, such as chip-based and paper-based biosensors. These biosensors could potentially substitute the conventional bulky and expensive diagnostic systems (e.g., microplate readers, thermocyclers, etc.) This Special Issue aims to discuss the recent advances in POC biosensors for medical diagnosis.

Topics include, but are not limited to, the development of chip-based and paper-based POC biosensors for the detection of disease-specific biomarkers, based on colorimetric, fluorescent and electrochemical detection. We invite researchers to share their knowledge by contributing relevant original research articles, short communications and review articles.

Dr. Jane Ru Choi
Dr. Kar Wey Yong
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • point-of-care biosensors
  • paper-based biosensors
  • chip-based biosensors
  • medical diagnosis
  • biomarkers
  • nucleic acids
  • antibodies and antigens

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

21 pages, 4905 KiB  
Review
Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease
by Riccarda Antiochia
Biosensors 2021, 11(4), 110; https://doi.org/10.3390/bios11040110 - 07 Apr 2021
Cited by 39 | Viewed by 7470
Abstract
This review summarizes the state of the art of paper-based biosensors (PBBs) for coronavirus disease 2019 (COVID-19) detection. Three categories of PBB are currently being been used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, namely for viral gene, viral antigen and [...] Read more.
This review summarizes the state of the art of paper-based biosensors (PBBs) for coronavirus disease 2019 (COVID-19) detection. Three categories of PBB are currently being been used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, namely for viral gene, viral antigen and antibody detection. The characteristics, the analytical performance, the advantages and drawbacks of each type of biosensor are highlighted and compared with traditional methods. It is hoped that this review will be useful for scientists for the development of novel PBB platforms with enhanced performance for helping to contain the COVID-19 outbreak, by allowing early diagnosis at the point of care (POC). Full article
(This article belongs to the Special Issue Point-of-Care Biosensors for Medical Diagnosis)
Show Figures

Figure 1

Back to TopTop